These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 18172817)
1. Secretion of thymidine kinase to increase the effectivity of suicide gene therapy results in the loss of enzymatic activity. Beerens AM; Rots MG; Bermúdez B; de Vries EF; Haisma HJ J Drug Target; 2008 Jan; 16(1):26-35. PubMed ID: 18172817 [TBL] [Abstract][Full Text] [Related]
2. Fusion of herpes simplex virus thymidine kinase to VP22 does not result in intercellular trafficking of the protein. Beerens AM; Rots MG; de Vries EF; Haisma HJ Int J Mol Med; 2007 May; 19(5):841-9. PubMed ID: 17390091 [TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing. Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705 [TBL] [Abstract][Full Text] [Related]
4. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control. Mathis JM; Williams BJ; Sibley DA; Carroll JL; Li J; Odaka Y; Barlow S; Nathan CO; Li BD; DeBenedetti A J Gene Med; 2006 Sep; 8(9):1105-20. PubMed ID: 16802401 [TBL] [Abstract][Full Text] [Related]
5. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines]. Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864 [TBL] [Abstract][Full Text] [Related]
6. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death. Liu CS; Kong B; Xia HH; Ellem KA; Wei MQ J Gene Med; 2001; 3(2):145-52. PubMed ID: 11318113 [TBL] [Abstract][Full Text] [Related]
7. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
8. Intercellular trafficking and cytotoxicity of recombinant HSV-1 thymidine kinase fused with HSV-2 US11 RXP repeat peptide. Luo C; Nawa A; Yamauchi Y; Kohno S; Ushijima Y; Goshima F; Kikkawa F; Nishiyama Y Virus Genes; 2007 Jun; 34(3):263-72. PubMed ID: 16927131 [TBL] [Abstract][Full Text] [Related]
9. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy. Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy. Xie Y; Gilbert JD; Kim JH; Freytag SO Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364 [TBL] [Abstract][Full Text] [Related]
12. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Tang Q; Zhang D; Wan M; Jin L Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766 [TBL] [Abstract][Full Text] [Related]
13. Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinase. Moriuchi S; Glorioso JC; Maruno M; Izumoto S; Wolfe D; Huang S; Cohen JB; Yoshimine T Cancer Gene Ther; 2005 May; 12(5):487-96. PubMed ID: 15692608 [TBL] [Abstract][Full Text] [Related]
14. Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification. Couderc BC; de Neuville S; Douin-Echinard V; Serres B; Manenti S; Darbon JM; Malecaze F Curr Eye Res; 1999 Dec; 19(6):472-82. PubMed ID: 10550788 [TBL] [Abstract][Full Text] [Related]
15. Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase. Degrève B; Esnouf R; De Clercq E; Balzarini J Mol Pharmacol; 2001 Feb; 59(2):285-93. PubMed ID: 11160865 [TBL] [Abstract][Full Text] [Related]
16. Gene therapy for adult T cell leukemia using human immunodeficiency virus vector carrying the thymidine kinase gene of herpes simplex virus type 1. Obaru K; Fujii S; Matsushita S; Shimada T; Takatsuki K Hum Gene Ther; 1996 Dec; 7(18):2203-8. PubMed ID: 8953310 [TBL] [Abstract][Full Text] [Related]
17. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase. Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso JC Cancer Res; 1998 Dec; 58(24):5731-7. PubMed ID: 9865731 [TBL] [Abstract][Full Text] [Related]